{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:12:12Z","timestamp":1791493932751,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CSASI24jul-0005"],"award-info":[{"award-number":["CSASI24jul-0005"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arbres.2025.09.017","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:24:34Z","timestamp":1759591474000},"page":"757-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Charting the Course in Post-Tuberculosis Lung Disease: From Inflammation to Intervention"],"prefix":"10.1016","volume":"61","author":[{"given":"Win Pa Pa","family":"Thu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting Huey","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Centis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine W.M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2025.09.017_bib0405","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.arbres.2025.09.017_bib0410","first-page":"150","article-title":"Insights from the 2024 WHO Global Tuberculosis Report \u2013 More Comprehensive Action Innovation, and Investments required for achieving WHO End TB goals","author":"Goletti","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.arbres.2025.09.017_bib0415","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"Dodd","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.arbres.2025.09.017_bib0420","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5588\/ijtld.20.0488","article-title":"Post-tuberculosis sequelae: the need to look beyond treatment outcome","volume":"24","author":"Visca","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.arbres.2025.09.017_bib0425","doi-asserted-by":"crossref","first-page":"820","DOI":"10.5588\/ijtld.20.0067","article-title":"Post-tuberculosis lung health: perspectives from the First International Symposium","volume":"24","author":"Allwood","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.arbres.2025.09.017_bib0430","first-page":"59","article-title":"Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis","author":"Taylor","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.arbres.2025.09.017_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000805","article-title":"Magnitude and factors associated with post-tuberculosis lung disease in low-and middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Maleche-Obimbo","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"02","key":"10.1016\/j.arbres.2025.09.017_bib0440","article-title":"Post-tuberculosis lung disease: a comparison of Brazilian Italian, and Mexican cohorts","volume":"48","author":"Silva","year":"2022","journal-title":"J Bras Pneumol"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0445","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12890-025-03549-5","article-title":"The prevalence and pattern of post tuberculosis lung disease including pulmonary hypertension from an Australian TB service; a single-centre, retrospective cohort study","volume":"25","author":"Byrne","year":"2025","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0450","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thorax.55.1.32","article-title":"Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment","volume":"55","author":"Hnizdo","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2025.09.017_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-016-0213-5","article-title":"Lung functions among patients with pulmonary tuberculosis in Dar es Salaam \u2013 a cross-sectional study","volume":"16","author":"Manji","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"10","key":"10.1016\/j.arbres.2025.09.017_bib0460","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0465","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1473-3099(19)30518-3","article-title":"Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in S\u00e3o Paulo state Brazil, 2010\u201315: a population-based, longitudinal study","volume":"20","author":"Ranzani","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.arbres.2025.09.017_bib0470","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5588\/ijtld.22.0514","article-title":"Post-TB health and wellbeing","volume":"27","author":"Nightingale","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1016\/j.arbres.2025.09.017_bib0475","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5588\/ijtldopen.25.0222","article-title":"Beyond a cure for TB: confronting the hidden burden of post-TB lung disease","volume":"2","author":"Kherabi","year":"2025","journal-title":"IJTLD Open"},{"issue":"9","key":"10.1016\/j.arbres.2025.09.017_bib0480","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5588\/ijtld.24.0029","article-title":"Lung function and health-related quality of life among adult patients following pulmonary TB treatment","volume":"28","author":"Zawedde","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"issue":"147.","key":"10.1016\/j.arbres.2025.09.017_bib0485","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"12","key":"10.1016\/j.arbres.2025.09.017_bib0490","doi-asserted-by":"crossref","first-page":"e1679","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae","volume":"9","author":"Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.arbres.2025.09.017_bib0495","article-title":"Follow-up of patients diagnosed with and treated for tuberculosis in Brazil: financial burden on the household","volume":"49","author":"Loureiro","year":"2023","journal-title":"J Bras Pneumol"},{"issue":"4","key":"10.1016\/j.arbres.2025.09.017_bib0500","article-title":"The catastrophic cost of TB care: Understanding costs incurred by individuals undergoing TB care in low-, middle-, and high-income settings \u2013 a systematic review","volume":"5","author":"D'Silva","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.arbres.2025.09.017_bib0505","first-page":"191","article-title":"The challenge of post-tuberculosis lung disease","author":"Rachow","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.arbres.2025.09.017_bib0510","first-page":"365","article-title":"Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities","volume":"44","author":"Hunter","year":"2014","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.arbres.2025.09.017_bib0515","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3389\/fmicb.2018.02603","article-title":"The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy","volume":"9","author":"Stek","year":"2018","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.arbres.2025.09.017_bib0520","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1164\/rccm.202402-0374SO","article-title":"Pathogenesis of post-tuberculosis lung disease: defining knowledge gaps and research priorities at the second international post-tuberculosis symposium","volume":"210","author":"Auld","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.arbres.2025.09.017_bib0525","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"102","key":"10.1016\/j.arbres.2025.09.017_bib0530","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado5951","article-title":"Immunopathology in human tuberculosis","volume":"9","author":"Scriba","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.arbres.2025.09.017_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102244","article-title":"Immunologic and imaging signatures in post tuberculosis lung disease","volume":"136","author":"Singh","year":"2022","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.arbres.2025.09.017_bib0540","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","article-title":"Cavitary tuberculosis: the gateway of disease transmission","volume":"20","author":"Urbanowski","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.arbres.2025.09.017_bib0545","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/idr17030052","article-title":"Delineating the significance of several inflammatory markers in a lung tuberculosis cohort during the active and post-tuberculosis stages of the disease: an observational study in Cape Town South Africa (2019\u20132024)","volume":"17","author":"Jumaar","year":"2025","journal-title":"Infect Dis Rep"},{"issue":"10","key":"10.1016\/j.arbres.2025.09.017_bib0550","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.arbres.2025.09.017_bib0555","article-title":"To treat or not to treat tuberculosis \u2013 clinical decision making in patients with previous pulmonary tuberculosis using 18F-FDG PET\/CT","volume":"46","author":"G\u00fcnther","year":"2023","journal-title":"Respir Med Case Rep"},{"issue":"2","key":"10.1016\/j.arbres.2025.09.017_bib0560","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0565","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis pulmonary cavitation matrix metalloproteinases","volume":"190","author":"Ong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.arbres.2025.09.017_bib0570","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2012.07.003","article-title":"Interleukin-6: from an inflammatory marker to a target for inflammatory diseases","volume":"33","author":"Rincon","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.arbres.2025.09.017_bib0575","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(24)00429-6","article-title":"Post-tuberculosis lung disease: towards prevention, diagnosis, and care","author":"Meghji","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.arbres.2025.09.017_bib0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161176","article-title":"A systematic review of the prevalence and pattern of imaging defined post-TB lung disease","volume":"11","author":"Meghji","year":"2016","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0585","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00390-2020","article-title":"Higher interleukin-6 levels and changes in transforming growth factor-\u03b2 are associated with lung impairment in pulmonary tuberculosis","volume":"7","author":"Gupte","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.arbres.2025.09.017_bib0590","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.740933","article-title":"Major neutrophil-derived soluble mediators associate with baseline lung pathology and post-treatment recovery in tuberculosis patients","volume":"12","author":"Muefong","year":"2021","journal-title":"Front Immunol"},{"issue":"168","key":"10.1016\/j.arbres.2025.09.017_bib0595","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0221-2022","article-title":"Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people","volume":"32","author":"Ivanova","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"10","key":"10.1016\/j.arbres.2025.09.017_bib0600","doi-asserted-by":"crossref","first-page":"797","DOI":"10.5588\/ijtld.21.0425","article-title":"Clinical standards for the assessment, management and rehabilitation of post-TB lung disease","volume":"25","author":"Migliori","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.arbres.2025.09.017_bib0605","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1431881","article-title":"\u201cYou find yourself in a very humiliating situation\u201d: experiences of people living with post-tuberculosis lung disease in Brazil","volume":"12","author":"Almeida","year":"2024","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0610","doi-asserted-by":"crossref","first-page":"16354","DOI":"10.1038\/s41598-022-20833-0","article-title":"Prevalence of cardiovascular risk factors in active tuberculosis in Africa: a systematic review and meta-analysis","volume":"12","author":"Baluku","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.arbres.2025.09.017_bib0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235821","article-title":"Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Basham","year":"2020","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.arbres.2025.09.017_bib0620","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000543319","article-title":"Pulmonary tuberculosis and risk of lung cancer: a systematic review and meta-analysis","volume":"104","author":"Sodeifian","year":"2025","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.arbres.2025.09.017_bib0625","doi-asserted-by":"crossref","first-page":"E1020","DOI":"10.1016\/S2214-109X(25)00105-6","article-title":"Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis","volume":"13","author":"Ratnakumar","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.arbres.2025.09.017_bib0630","article-title":"Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease","volume":"49","author":"Silva","year":"2023","journal-title":"J Bras Pneumol"},{"issue":"4","key":"10.1016\/j.arbres.2025.09.017_bib0635","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5588\/ijtld.20.0906","article-title":"Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function","volume":"25","author":"Allwood","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.arbres.2025.09.017_bib0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102898","article-title":"Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis","volume":"77","author":"Akalu","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"4.","key":"10.1016\/j.arbres.2025.09.017_bib0645","article-title":"Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study","volume":"59","author":"Gupte","year":"2022","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.arbres.2025.09.017_bib0650","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27754","article-title":"Association of plasma matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase levels with adverse treatment outcomes among patients with pulmonary tuberculosis","volume":"3","author":"Kumar","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arbres.2025.09.017_bib0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110817","article-title":"Post-tuberculosis lung disease and inflammatory role players: can we characterise the myriad inflammatory pathways involved to gain a better understanding?","volume":"387","author":"Malefane","year":"2024","journal-title":"Chem Biol Interact"},{"issue":"5","key":"10.1016\/j.arbres.2025.09.017_bib0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5588\/ijtld.25.0157","article-title":"Registries for bronchiectasis in the world: an opportunity for international collaboration","volume":"29","author":"Oscullo","year":"2025","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.arbres.2025.09.017_bib0665","doi-asserted-by":"crossref","first-page":"e20250153","DOI":"10.36416\/1806-3756\/e20250153","article-title":"Post-tuberculosis and postinfected bronchiectasis: data from global registries","volume":"51","author":"Oscullo","year":"2025","journal-title":"Jornal Brasileiro de Pneumologia"},{"issue":"12","key":"10.1016\/j.arbres.2025.09.017_bib0670","doi-asserted-by":"crossref","first-page":"600","DOI":"10.5588\/ijtld.24.0163","article-title":"Chronic pulmonary aspergillosis in patients with post-TB sequelae","volume":"28","author":"Gupta","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.arbres.2025.09.017_bib0675","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1017\/S0950268817000279","article-title":"Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis","volume":"145","author":"Huaman","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.arbres.2025.09.017_bib0680","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5588\/ijtldopen.23.0619","article-title":"Perspectives from the 2nd International Post-Tuberculosis symposium: mobilising advocacy and research for improved outcomes","volume":"1","author":"Allwood","year":"2024","journal-title":"IJTLD Open"},{"issue":"2","key":"10.1016\/j.arbres.2025.09.017_bib0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5588\/ijtld.23.0524","article-title":"The potential for vaccines to aid the treatment of post-TB lung disease","volume":"28","author":"Silva","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.arbres.2025.09.017_bib0690","article-title":"Vaccination in post-tuberculosis lung disease management: a review of the evidence","author":"Nasiri","year":"2023","journal-title":"Pulmonology"},{"issue":"3","key":"10.1016\/j.arbres.2025.09.017_bib0695","first-page":"6","article-title":"Recomendaciones para el manejo de la enfermedad pulmonar post tuberculosis","volume":"16","author":"Janete Inwentarz","year":"2024","journal-title":"Respirar"},{"issue":"4","key":"10.1016\/j.arbres.2025.09.017_bib0700","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tips.2021.11.016","article-title":"Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches","volume":"43","author":"Mehta","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.arbres.2025.09.017_bib0705","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1806-37562016000000226","article-title":"Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?","volume":"42","author":"Mu\u00f1oz-Torrico","year":"2016","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.arbres.2025.09.017_bib0710","first-page":"00077","article-title":"Post-TB Lung Disease: where are we to respond to this priority?","author":"Silva","year":"2025","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.arbres.2025.09.017_bib0715","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02184-2018","article-title":"Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae","volume":"53","author":"Visca","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2025.09.017_bib0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.arbres.2025.02.007","article-title":"Pulmonary rehabilitation in patients with post-tuberculosis lung disease: a prospective multicentre study","author":"Silva","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2025.09.017_bib0725","first-page":"70","article-title":"Interventions to prevent post-tuberculosis sequelae: a systematic review and meta-analysis","author":"Alene","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.arbres.2025.09.017_bib0730","article-title":"A mouse model of TB-associated lung fibrosis reveals persistent inflammatory macrophage populations during treatment","author":"Boucau","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0735","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1038\/s41467-025-58190-x","article-title":"Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis","volume":"16","author":"Singh","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.arbres.2025.09.017_bib0740","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-022-02387-0","article-title":"Nos2\u2212\/\u2212 mice infected with M. tuberculosis develop neurobehavioral changes and immunopathology mimicking human central nervous system tuberculosis","volume":"19","author":"Poh","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"9","key":"10.1016\/j.arbres.2025.09.017_bib0745","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/AAC.00276-07","article-title":"Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910","volume":"51","author":"Lenaerts","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2025.09.017_bib0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-11-49","article-title":"A modified scoring system to describe gross pathology in the rabbit model of tuberculosis","volume":"11","author":"Jassal","year":"2011","journal-title":"BMC Microbiol"},{"issue":"9","key":"10.1016\/j.arbres.2025.09.017_bib0755","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/AAC.00277-13","article-title":"Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens","volume":"57","author":"Lin","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.arbres.2025.09.017_bib0760","article-title":"Adjunctive steroid therapy for managing pulmonary tuberculosis","volume":"2014","author":"Critchley","year":"1996","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2025.09.017_bib0765","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33478","article-title":"A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults","volume":"7","author":"Mai","year":"2018","journal-title":"Elife"},{"issue":"15","key":"10.1016\/j.arbres.2025.09.017_bib0770","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.arbres.2025.09.017_bib0775","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.arbres.2025.09.017_bib0780","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300332","article-title":"Adjunctive N-acetylcysteine and lung function in pulmonary tuberculosis","volume":"3","author":"Wallis","year":"2024","journal-title":"NEJM Evid"},{"key":"10.1016\/j.arbres.2025.09.017_bib0785","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaf069","article-title":"Azithromycin as host-directed therapy for pulmonary tuberculosis \u2013 a randomized pilot trial","author":"Dekkers","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbres.2025.09.017_bib0790","series-title":"Integrated approach to tuberculosis and lung health: policy brief","author":"Organization","year":"2025"},{"key":"10.1016\/j.arbres.2025.09.017_bib0795","series-title":"Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions, 17-19 November 2020. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions, 17\u201319 November 2020","year":"2021"},{"key":"10.1016\/j.arbres.2025.09.017_bib0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.arbres.2025.03.020","article-title":"Whither TB: is the elimination goal realistic after the double shock?","author":"Silva","year":"2025","journal-title":"Arch Bronconeumol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289625003412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289625003412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:02:20Z","timestamp":1764601340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289625003412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0300289625003412"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2025.09.017","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Charting the Course in Post-Tuberculosis Lung Disease: From Inflammation to Intervention","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2025.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}